Search research articles
Contact Us
Filters
Showing results (141-150 of 172) with videos related to
Page
of 18
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 15, 2000
Value of peptide receptor scintigraphy using (123)I-vasoactive intestinal peptide and (111)In-DTPA-D-Phe1-octreotide in 194 carcinoid patients: Vienna University Experience, 1993 to 1998
M Raderer, A Kurtaran, M Leimer, et al.
Gut
|
February 15, 2011
EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT
A Ruskoné-Fourmestraux, W Fischbach, B M P Aleman, et al.
British Journal of Cancer
|
September 1, 1999
Phase II trial of gemcitabine, epirubicin and granulocyte colony-stimulating factor in patients with advanced pancreatic adenocarcinoma
W Scheithauer, G V Kornek, M Raderer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 7, 2008
Rituximab monotherapy for primary cutaneous B-cell lymphoma: response and follow-up in 16 patients
J Valencak, F Weihsengruber, K Rappersberger, et al.
Liver
|
February 13, 2001
18F-fluorodeoxyglucose (FDG)-PET features of focal nodular hyperplasia (FNH) of the liver
A Kurtaran, A Becherer, F Pfeffel, et al.
Cancer
|
June 22, 2000
A phase II trial of biweekly high dose gemcitabine for patients with metastatic pancreatic adenocarcinoma
H Ulrich-Pur, G V Kornek, M Raderer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 18, 2022
Corrigendum to "Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology 31 (2020) 17-29]
E Zucca, L Arcaini, C Buske, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 6, 2004
Cytotoxic activity of camptothecin and paclitaxel in newly established continuous human medullary thyroid carcinoma cell lines
K Kaczirek, M Schindl, A Weinhäusel, et al.
British Journal of Cancer
|
February 23, 1999
Treatment of advanced pancreatic cancer with the long-acting somatostatin analogue lanreotide: in vitro and in vivo results
M Raderer, G Hamilton, A Kurtaran, et al.
Oncology
|
April 15, 1999
Two consecutive phase II studies of 5-fluorouracil/leucovorin/mitomycin C and of gemcitabine in patients with advanced biliary cancer
M Raderer, M H Hejna, J B Valencak, et al.
Page
of 18
Search research articles
Search
Showing results (141-150 of 172) with videos related to
Sort By:
Page
of 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 15, 2000
Value of peptide receptor scintigraphy using (123)I-vasoactive intestinal peptide and (111)In-DTPA-D-Phe1-octreotide in 194 carcinoid patients: Vienna University Experience, 1993 to 1998
M Raderer, A Kurtaran, M Leimer, et al.
Gut
|
February 15, 2011
EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT
A Ruskoné-Fourmestraux, W Fischbach, B M P Aleman, et al.
British Journal of Cancer
|
September 1, 1999
Phase II trial of gemcitabine, epirubicin and granulocyte colony-stimulating factor in patients with advanced pancreatic adenocarcinoma
W Scheithauer, G V Kornek, M Raderer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 7, 2008
Rituximab monotherapy for primary cutaneous B-cell lymphoma: response and follow-up in 16 patients
J Valencak, F Weihsengruber, K Rappersberger, et al.
Liver
|
February 13, 2001
18F-fluorodeoxyglucose (FDG)-PET features of focal nodular hyperplasia (FNH) of the liver
A Kurtaran, A Becherer, F Pfeffel, et al.
Cancer
|
June 22, 2000
A phase II trial of biweekly high dose gemcitabine for patients with metastatic pancreatic adenocarcinoma
H Ulrich-Pur, G V Kornek, M Raderer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 18, 2022
Corrigendum to "Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology 31 (2020) 17-29]
E Zucca, L Arcaini, C Buske, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 6, 2004
Cytotoxic activity of camptothecin and paclitaxel in newly established continuous human medullary thyroid carcinoma cell lines
K Kaczirek, M Schindl, A Weinhäusel, et al.
British Journal of Cancer
|
February 23, 1999
Treatment of advanced pancreatic cancer with the long-acting somatostatin analogue lanreotide: in vitro and in vivo results
M Raderer, G Hamilton, A Kurtaran, et al.
Oncology
|
April 15, 1999
Two consecutive phase II studies of 5-fluorouracil/leucovorin/mitomycin C and of gemcitabine in patients with advanced biliary cancer
M Raderer, M H Hejna, J B Valencak, et al.
Page
of 18